Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tci GeneROCO:6879 64 3-Year ROIIC % is -299.12 as of Dec. 2025. GuruFocus rates ROCO:6879 with a GF Score™ of 64/100 and a GF Value™ of NT$48.58 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 1,320 Biotechnology companies, Tci Gene ranks worse than 83.79% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Tci Gene's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was -299.12%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Tci Gene's 3-Year ROIIC % or its related term are showing as below:
ROCO:6879's 3-Year ROIIC % is ranked worse than 83.79% of 1320
companies
in the Biotechnology industry
Industry Median: -4.835
vs ROCO:6879: -299.12
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Tci Gene 3-Year ROIIC % Related Terms
Tci Gene 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Tci Gene's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6879 vs VRTX, REGN, RVMD: 3-Year ROIIC % Comparison
For the Biotechnology subindustry, Tci Gene's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tci Gene 3-Year ROIIC % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Tci Gene's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Tci Gene's 3-Year ROIIC % falls into.
Tci Gene's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( 19.075 (Dec. 2025) - 75.1368056 (Dec. 2022) )
/
( 117.523 (Dec. 2025) - 98.781 (Dec. 2022) )
=
-56.0618056
/
18.742
=
-299.12%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Tci Gene (ROCO:6879) has a 3-Year ROIIC % of -299.12 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Tci Gene and its competitors. According to the industry distribution chart, Tci Gene ranks #1106 out of 1320 companies in the Biotechnology industry, placing it in the top 83.8%.
Is Tci Gene's 3-Year ROIIC % too high?
Tci Gene's current 3-Year ROIIC % is -299.12. Based on the distribution chart, Tci Gene ranks #1106 out of 1320 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Tci Gene has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Tci Gene's 3-Year ROIIC % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Tci Gene ranks #1106 out of 1320 companies for 3-Year ROIIC %. This places Tci Gene in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Biotechnology company?
A good 3-Year ROIIC % depends on the Biotechnology industry context. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Tci Gene and its competitors. Tci Gene's current 3-Year ROIIC % is -299.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tci Gene stock overvalued right now?
Based on GuruFocus' analysis, Tci Gene (ROCO:6879) is currently considered Possible Value Trap. The stock's GF Value™ is NT$48.58, compared to a current price of NT$34.00 — trading 30% below its estimated fair value. The current 3-Year ROIIC % is -299.12. Tci Gene's overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Tci Gene (ROCO:6879), the current 3-Year ROIIC % is -299.12 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tci Gene (ROCO:6879) Overvalued in 2026?
Based on GuruFocus' analysis, Tci Gene stock appears to be undervalued.
The current stock price of NT$34.00 is trading 30% below its estimated GF Value™ of NT$48.58.
GuruFocus considers Tci Gene to be Possible Value Trap.
Key valuation signals for ROCO:6879:
3-Year ROIIC %: -299.12
GF Value™: NT$48.58 vs. price of NT$34.00 (30% below fair value)
No single metric tells the full story. See the ROCO:6879 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tci Gene Inc provides precision preventive medicines in Taiwan. It is the first to introduce the concept of precision preventive medicine with Predict prediction, Prevent prevention, and Personal Treatment personalized health management measures.
64GF Score
Get the complete analysis for ROCO:6879
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6879 has been successfully added to your 
